{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:39:07Z","timestamp":1792669147590,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"DOI":"10.1215\/15228517-2007-058","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T02:05:41Z","timestamp":1203559541000},"page":"199-207","source":"Crossref","is-referenced-by-count":179,"title":["Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features"],"prefix":"10.1093","volume":"10","author":[{"given":"Jeffrey J.","family":"Raizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jen","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Panageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew E.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"von Althann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne A.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Bilsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Gutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"key\n\t\t\t\t20171013050435_REF1","doi-asserted-by":"crossref","unstructured":"Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 1978;42: 660-668.","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E"},{"key":"key\n\t\t\t\t20171013050435_REF2","doi-asserted-by":"crossref","unstructured":"Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg. 1978;135: 807-810.","DOI":"10.1016\/0002-9610(78)90171-X"},{"key":"key\n\t\t\t\t20171013050435_REF3","doi-asserted-by":"crossref","unstructured":"Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88: 11-20.","DOI":"10.3171\/jns.1998.88.1.0011"},{"key":"key\n\t\t\t\t20171013050435_REF4","doi-asserted-by":"crossref","unstructured":"Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH. Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer. 2002;94: 2265-2272.","DOI":"10.1002\/cncr.10426"},{"key":"key\n\t\t\t\t20171013050435_REF5","doi-asserted-by":"crossref","unstructured":"Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys. 2001;49: 93-97.","DOI":"10.1016\/S0360-3016(00)01355-9"},{"key":"key\n\t\t\t\t20171013050435_REF6","doi-asserted-by":"crossref","unstructured":"Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22: 1293-1300.","DOI":"10.1200\/JCO.2004.08.140"},{"key":"key\n\t\t\t\t20171013050435_REF7","doi-asserted-by":"crossref","unstructured":"Harrison BE, Johnson JL, Clough RW, Halperin EC. Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol. 2003;26: 354-357.","DOI":"10.1097\/01.COC.0000020963.71379.FE"},{"key":"key\n\t\t\t\t20171013050435_REF8","doi-asserted-by":"crossref","unstructured":"Mendez IM, Del Maestro RF. Cerebral metastases from malignant melanoma. Can J Neurol Sci. 1988;15: 119-123.","DOI":"10.1017\/S0317167100027463"},{"key":"key\n\t\t\t\t20171013050435_REF9","doi-asserted-by":"crossref","unstructured":"Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys. 1998;42: 581-589.","DOI":"10.1016\/S0360-3016(98)00272-7"},{"key":"key\n\t\t\t\t20171013050435_REF10","doi-asserted-by":"crossref","unstructured":"Overett TK, Shiu MH. Surgical treatment of distant metastatic melanoma. Indications and results. Cancer. 1985;56: 1222-1230.","DOI":"10.1002\/1097-0142(19850901)56:5<1222::AID-CNCR2820560544>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20171013050435_REF11","doi-asserted-by":"crossref","unstructured":"Saha S, Meyer M, Krementz ET, et al. Prognostic evaluation of intracranial metastasis in malignant melanoma. Ann Surg Oncol. 1994;1: 38-44.","DOI":"10.1007\/BF02303539"},{"key":"key\n\t\t\t\t20171013050435_REF12","doi-asserted-by":"crossref","unstructured":"Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg. 2002;96: 552-558.","DOI":"10.3171\/jns.2002.96.3.0552"},{"key":"key\n\t\t\t\t20171013050435_REF13","doi-asserted-by":"crossref","unstructured":"Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol. 1983;1: 313-317.","DOI":"10.1007\/BF00165714"},{"key":"key\n\t\t\t\t20171013050435_REF14","doi-asserted-by":"crossref","unstructured":"Choi KN, Withers HR, Rotman M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer. 1985;56: 1-9.","DOI":"10.1002\/1097-0142(19850701)56:1<1::AID-CNCR2820560102>3.0.CO;2-X"},{"key":"key\n\t\t\t\t20171013050435_REF15","doi-asserted-by":"crossref","unstructured":"Grob JJ, Regis J, Laurans R, et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cance\u0301rologie Cutane\u0301e. Eur J Cancer. 1998;34: 1187-1192.","DOI":"10.1016\/S0959-8049(98)00026-4"},{"key":"key\n\t\t\t\t20171013050435_REF16","doi-asserted-by":"crossref","unstructured":"Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg. 2000;93: 9-18.","DOI":"10.3171\/jns.2000.93.1.0009"},{"key":"key\n\t\t\t\t20171013050435_REF17","doi-asserted-by":"crossref","unstructured":"Yu C, Chen JC, Apuzzo ML, et al. Metastatic melanoma to the brain: prognostic factors after Gamma Knife radiosurgery. Int J Radiat Oncol Biol Phys. 2002;52: 1277-1287.","DOI":"10.1016\/S0360-3016(01)02772-9"},{"key":"key\n\t\t\t\t20171013050435_REF18","doi-asserted-by":"crossref","unstructured":"Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19: 3635-3648.","DOI":"10.1200\/JCO.2001.19.16.3635"},{"key":"key\n\t\t\t\t20171013050435_REF19","doi-asserted-by":"crossref","unstructured":"Cox D. Regression models and life tables. J R Stat Soc (B). 1972;34: 187-220.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"key\n\t\t\t\t20171013050435_REF20","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"key\n\t\t\t\t20171013050435_REF21","doi-asserted-by":"crossref","unstructured":"Hagen NA, Cirrincione C, Thaler HT, DeAngelis LM. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology. 1990;40: 158-160.","DOI":"10.1212\/WNL.40.1.158"},{"key":"key\n\t\t\t\t20171013050435_REF22","doi-asserted-by":"crossref","unstructured":"Meier S, Baumert BG, Maier T, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie. 2004;27: 145-149.","DOI":"10.1159\/000076903"},{"key":"key\n\t\t\t\t20171013050435_REF23","doi-asserted-by":"crossref","unstructured":"Morris SL, Low SH, A'Hern RP, et al. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer. 2004;91: 829-833.","DOI":"10.1038\/sj.bjc.6602018"},{"key":"key\n\t\t\t\t20171013050435_REF24","doi-asserted-by":"crossref","unstructured":"Brand CU, Ellwanger U, Stroebel W, et al. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer. 1997;79: 2345-2353.","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K"},{"key":"key\n\t\t\t\t20171013050435_REF25","doi-asserted-by":"crossref","unstructured":"Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37: 745-751.","DOI":"10.1016\/S0360-3016(96)00619-0"},{"key":"key\n\t\t\t\t20171013050435_REF26","doi-asserted-by":"crossref","unstructured":"Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47: 1001-1006.","DOI":"10.1016\/S0360-3016(00)00547-2"},{"key":"key\n\t\t\t\t20171013050435_REF27","doi-asserted-by":"crossref","unstructured":"Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol. 2005;71: 307-313.","DOI":"10.1007\/s11060-004-2027-1"},{"key":"key\n\t\t\t\t20171013050435_REF28","doi-asserted-by":"crossref","unstructured":"Kondziolka D, Bernstein M, Resch L, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67: 852-857.","DOI":"10.3171\/jns.1987.67.6.0852"},{"key":"key\n\t\t\t\t20171013050435_REF29","doi-asserted-by":"crossref","unstructured":"Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer. 1984;53: 2550-2552.","DOI":"10.1002\/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B"},{"key":"key\n\t\t\t\t20171013050435_REF30","doi-asserted-by":"crossref","unstructured":"Radbill AE, Fiveash JF, Falkenberg ET, et al. Initial treatment of melanoma brain metastases using Gamma Knife radiosurgery: an evaluation of efficacy and toxicity. Cancer. 2004;101: 825-833.","DOI":"10.1002\/cncr.20447"},{"key":"key\n\t\t\t\t20171013050435_REF31","unstructured":"Seung SK, Sneed PK, McDermott MW, et al. Gamma Knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am. 1998;4: 103-109."},{"key":"key\n\t\t\t\t20171013050435_REF32","doi-asserted-by":"crossref","unstructured":"Selek U, Chang EL, Hassenbusch SJ III, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004;59: 1097-1106.","DOI":"10.1016\/j.ijrobp.2003.12.037"},{"key":"key\n\t\t\t\t20171013050435_REF33","doi-asserted-by":"crossref","unstructured":"Manon R, O'Neill A, Knisely J, et al.; Eastern Cooperative Oncology Group. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol. 2005;23: 8870-8876.","DOI":"10.1200\/JCO.2005.01.8747"},{"key":"key\n\t\t\t\t20171013050435_REF34","doi-asserted-by":"crossref","unstructured":"Franciosi V, Cocconi G, Michiara M, et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer. 1999;85: 1599-1605.","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1599::AID-CNCR23>3.0.CO;2-#"},{"key":"key\n\t\t\t\t20171013050435_REF35","doi-asserted-by":"crossref","unstructured":"Kaba SE, Kyritsis AP, Hess K, et al. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. J Clin Oncol. 1997;15: 1063-1070.","DOI":"10.1200\/JCO.1997.15.3.1063"},{"key":"key\n\t\t\t\t20171013050435_REF36","doi-asserted-by":"crossref","unstructured":"Agarwala SS, Kirkwood JM, Gore M, et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol. 2004;22: 2101-2107.","DOI":"10.1200\/JCO.2004.11.044"},{"key":"key\n\t\t\t\t20171013050435_","doi-asserted-by":"crossref","unstructured":"Bafaloukos D, Gogas H, Georgoulias V, et al. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. J Clin Oncol. 2002;20: 420-425.","DOI":"10.1159\/000076908"},{"key":"key\n\t\t\t\t20171013050435_","doi-asserted-by":"crossref","unstructured":"Bafaloukos D, Tsoutsos D, Fountzilas G, et al. The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma. Melanoma Res. 2004;14: 289-294.","DOI":"10.1159\/000076908"},{"key":"key\n\t\t\t\t20171013050435_","doi-asserted-by":"crossref","unstructured":"Dvorak J, Melichar B, Zizka J, Hadzi-Nikolov D, Petera J. Complete response of multiple melanoma brain metastases after treatment with temozolomide. Onkologie. 2004;27: 171-174.","DOI":"10.1159\/000076908"},{"key":"key\n\t\t\t\t20171013050435_REF40","doi-asserted-by":"crossref","unstructured":"Hwu WJ, Lis E, Menell JH, et al. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. Cancer. 2005;103: 2590-2597.","DOI":"10.1002\/cncr.21081"},{"key":"key\n\t\t\t\t20171013050435_REF41","doi-asserted-by":"crossref","unstructured":"Paul MJ, Summers Y, Calvert AH, et al. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res. 2002;12: 175-178.","DOI":"10.1097\/00008390-200204000-00011"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/10\/2\/199\/13064880\/NO102_12_Raizer.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T05:17:13Z","timestamp":1557292633000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/10\/2\/199\/1076084\/Brain-and-leptomeningeal-metastases-from-cutaneous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,4,1]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2007-058","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,4]]},"published":{"date-parts":[[2008,4,1]]}}}